课题基金 / 基金详情

p53-dependent regulation of VEGF expression and activity

p53-dependent regulation of VEGF expression and activity
VEGF 表达和活性的 p53 依赖性调节
批准号:
6692662
负责人:
MARK W. JACKSON
金额:
$4.89万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-01 至 2005-12-31

项目摘要

项目成果

MARK W. JACKSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The observation that p53 mutation is strongly correlated with VEGF expression and increased vascular density demonstrates the significance of understanding the mechanisms utilized by p53 to control angiogenesis. Towards deciphering the role of p53 in regulating angiogenesis, three genes identified by gene array technology as p53- regulated have been chosen for further examination. Cutaneous fatty acid binding protein (cFABP), connective tissue growth factor (CTGF) and endothelial and smooth muscle cell-derived neuropilin-like molecule (ESDN) are regulated in a p53-dependent manner following induction by pl4ARF. The interest in each lies with their ability to alter VEGF expression or activity. The expression of cFABP, CTGF or ESDN has not previously been linked to p53 expression, an observation that may provide insight into the regulation of VEGF activities by p53. Given these observations, the focus of this proposed study is to decipher the roles, either separately or collectively, of cFABP, CTGF and ESDN in the regulation of YEGF-mediated tumor angiogenesis and metastasis. The findings of this study will allow a more thorough understanding of p53-mediated signaling in tumor angiogenesis and invasion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy
  • 批准号:
    10704231
  • 项目类别:
  • 资助金额:
    $39.32万
  • 财政年份:
    2022
  • 负责人:
    MARK W. JACKSON
  • 依托单位:
Shifting the balance between IFN-I and TGF-beta to improve cancer therapy
  • 批准号:
    10493939
  • 项目类别:
  • 资助金额:
    $40.09万
  • 财政年份:
    2022
  • 负责人:
    MARK W. JACKSON
  • 依托单位:
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
  • 批准号:
    10364703
  • 项目类别:
  • 资助金额:
    $40.46万
  • 财政年份:
    2021
  • 负责人:
    MARK W. JACKSON
  • 依托单位:
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
  • 批准号:
    10576854
  • 项目类别:
  • 资助金额:
    $40.46万
  • 财政年份:
    2021
  • 负责人:
    MARK W. JACKSON
  • 依托单位:
海外基金